Cannabinoid Biosynthesis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the global Cannabinoid Biosynthesis Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
The cannabinoid biosynthesis market focuses on the production of cannabinoids using advanced biotechnological methods such as microbial fermentation and synthetic biology. Unlike traditional plant extraction, biosynthesis enables the production of high-purity, consistent, and scalable cannabinoids such as CBD and THC. These bio-engineered compounds are widely used in pharmaceuticals, food & beverages, cosmetics, and wellness applications. The market is experiencing rapid growth due to increasing demand for sustainable production methods, advancements in biotechnology, and rising preference for clean-label and high-quality cannabinoid products. The ability to reduce dependence on cannabis cultivation while ensuring consistent quality is further accelerating market adoption globally.
Market Growth Drivers:
Several key factors are fueling the growth of the global cannabinoid biosynthesis market. The rising demand for sustainable and eco-friendly production methods is a major driver, as biosynthesis reduces reliance on agricultural cultivation and minimizes environmental impact. Increasing legalization of cannabis for medical and therapeutic use across multiple countries is further boosting demand for high-quality cannabinoids. Additionally, advancements in synthetic biology, including the use of engineered microbes and yeast-based platforms, are enabling cost-effective and scalable production. Growing consumer preference for pharmaceutical-grade, contaminant-free cannabinoids and the expanding application of these compounds in healthcare and wellness sectors are also contributing significantly to market expansion.
Market Restraints:
Despite its strong growth potential, the cannabinoid biosynthesis market faces several challenges. High initial investment costs associated with biotechnology infrastructure and R&D can limit market entry for smaller players. Regulatory complexities and lengthy approval processes from authorities such as the FDA and EMA can delay commercialization and increase compliance costs. Intellectual property disputes related to biosynthesis technologies may also create barriers for innovation and collaboration. Additionally, public skepticism toward synthetic biology and varying legal frameworks across regions can hinder widespread adoption.
Market Opportunities:
The cannabinoid biosynthesis market presents significant growth opportunities driven by continuous innovation and expanding application areas. Advances in metabolic engineering are enabling the production of rare cannabinoids such as CBG and CBN, which have strong therapeutic potential. Increasing investments in research and development, along with government support for sustainable biotechnology, are further accelerating market growth. Emerging markets in Asia Pacific and Latin America offer strong opportunities due to rising health awareness and expanding biotech infrastructure. Furthermore, strategic collaborations between biotech companies and pharmaceutical firms are expected to enhance commercialization and open new revenue streams in the coming years.
Key Questions Answered in the Report:
Leading companies in the global cannabinoid biosynthesis market are focusing on technological innovation, strategic partnerships, and expansion of production capabilities to strengthen their market position. Key players are investing in advanced microbial fermentation technologies and genetic engineering to improve production efficiency and reduce costs. Collaborations with pharmaceutical companies are enabling the development of high-purity, clinically validated cannabinoid products. Additionally, companies are expanding their product portfolios to include rare and customized cannabinoids, catering to diverse applications across healthcare, wellness, and consumer industries.
Companies Covered in This Report:
By Product Type
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Cannabinoid Biosynthesis Market Size (2025E): US$ 2.6 Bn
- Projected Market Value (2032F): US$ 6.6 Bn
- Global Market Growth Rate (CAGR 2025 to 2032): 14.2%
The cannabinoid biosynthesis market focuses on the production of cannabinoids using advanced biotechnological methods such as microbial fermentation and synthetic biology. Unlike traditional plant extraction, biosynthesis enables the production of high-purity, consistent, and scalable cannabinoids such as CBD and THC. These bio-engineered compounds are widely used in pharmaceuticals, food & beverages, cosmetics, and wellness applications. The market is experiencing rapid growth due to increasing demand for sustainable production methods, advancements in biotechnology, and rising preference for clean-label and high-quality cannabinoid products. The ability to reduce dependence on cannabis cultivation while ensuring consistent quality is further accelerating market adoption globally.
Market Growth Drivers:
Several key factors are fueling the growth of the global cannabinoid biosynthesis market. The rising demand for sustainable and eco-friendly production methods is a major driver, as biosynthesis reduces reliance on agricultural cultivation and minimizes environmental impact. Increasing legalization of cannabis for medical and therapeutic use across multiple countries is further boosting demand for high-quality cannabinoids. Additionally, advancements in synthetic biology, including the use of engineered microbes and yeast-based platforms, are enabling cost-effective and scalable production. Growing consumer preference for pharmaceutical-grade, contaminant-free cannabinoids and the expanding application of these compounds in healthcare and wellness sectors are also contributing significantly to market expansion.
Market Restraints:
Despite its strong growth potential, the cannabinoid biosynthesis market faces several challenges. High initial investment costs associated with biotechnology infrastructure and R&D can limit market entry for smaller players. Regulatory complexities and lengthy approval processes from authorities such as the FDA and EMA can delay commercialization and increase compliance costs. Intellectual property disputes related to biosynthesis technologies may also create barriers for innovation and collaboration. Additionally, public skepticism toward synthetic biology and varying legal frameworks across regions can hinder widespread adoption.
Market Opportunities:
The cannabinoid biosynthesis market presents significant growth opportunities driven by continuous innovation and expanding application areas. Advances in metabolic engineering are enabling the production of rare cannabinoids such as CBG and CBN, which have strong therapeutic potential. Increasing investments in research and development, along with government support for sustainable biotechnology, are further accelerating market growth. Emerging markets in Asia Pacific and Latin America offer strong opportunities due to rising health awareness and expanding biotech infrastructure. Furthermore, strategic collaborations between biotech companies and pharmaceutical firms are expected to enhance commercialization and open new revenue streams in the coming years.
Key Questions Answered in the Report:
- What are the primary factors driving the global cannabinoid biosynthesis market's growth?
- Which regions and market segments are experiencing the highest demand for biosynthesized cannabinoids?
- How are advancements in synthetic biology influencing market dynamics?
- Who are the key players in the cannabinoid biosynthesis market, and what strategies are they adopting?
- What are the emerging trends and future projections for the global market?
Leading companies in the global cannabinoid biosynthesis market are focusing on technological innovation, strategic partnerships, and expansion of production capabilities to strengthen their market position. Key players are investing in advanced microbial fermentation technologies and genetic engineering to improve production efficiency and reduce costs. Collaborations with pharmaceutical companies are enabling the development of high-purity, clinically validated cannabinoid products. Additionally, companies are expanding their product portfolios to include rare and customized cannabinoids, catering to diverse applications across healthcare, wellness, and consumer industries.
Companies Covered in This Report:
- Demetrix
- Ginkgo Bioworks
- Hyasynth Biologicals
- Creo
- Amyris Inc
- Zymergen Inc
- Cronos Group Inc
- Constellation Brands Inc
- Jazz Pharmaceuticals PLC
- Canopy Growth Corp
- Evolva Holding SA
- Willow Biosciences Inc
- InMed Pharmaceuticals
- CB Therapeutics
- Lygos
- Purisys
- Renew Biopharma
- Others
By Product Type
- Phytocannabinoids
- Synthetic Cannabinoids
- Endocannabinoid System
- Modulators
- Cannabinoids
- Cannabis Sativa
- Cannabis Indica
- Hemp-Derived Cannabinoids
- Others
- Pharmaceuticals
- Food and Beverages
- Cosmetics and Personal Care
- Healthcare Products
- Aromatherapy and Wellness
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
191 Pages
- 1. Executive Summary
- 1.1. Global Cannabinoid Biosynthesis Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. COVID-19 Impact Analysis
- 2.4. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Value Chain Analysis
- 3.2. Key Market Players
- 3.3. Regulatory Landscape
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 3.6. Consumer Behavior Analysis
- 4. Price Trend Analysis, 2019 - 2032
- 4.1. Key Factors Impacting Product Prices
- 4.2. Pricing Analysis, By Product Type
- 4.3. Regional Prices and Product Preferences
- 5. Global Cannabinoid Biosynthesis Market Outlook
- 5.1. Market Size (US$ Bn) Analysis and Forecast
- 5.1.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 5.1.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 5.2. Global Cannabinoid Biosynthesis Market Outlook: Product Type
- 5.2.1. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
- 5.2.2. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 5.2.2.1. Phytocannabinoids
- 5.2.2.2. Synthetic Cannabinoids
- 5.2.2.3. Endocannabinoid System
- 5.2.2.4. Modulators
- 5.2.2.5. Cannabinoids
- 5.2.3. Market Attractiveness Analysis: Product Type
- 5.3. Global Cannabinoid Biosynthesis Market Outlook: Source
- 5.3.1. Historical Market Size (US$ Bn) Analysis, By Source, 2019-2024
- 5.3.2. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 5.3.2.1. Cannabis Sativa
- 5.3.2.2. Cannabis Indica
- 5.3.2.3. Hemp-Derived Cannabinoids
- 5.3.2.4. Others
- 5.3.3. Market Attractiveness Analysis: Source
- 5.4. Global Cannabinoid Biosynthesis Market Outlook: Application
- 5.4.1. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 5.4.2. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 5.4.2.1. Pharmaceuticals
- 5.4.2.2. Food and Beverages
- 5.4.2.3. Cosmetics and Personal Care
- 5.4.2.4. Healthcare Products
- 5.4.2.5. Aromatherapy and Wellness
- 5.4.2.6. Others
- 5.4.3. Market Attractiveness Analysis: Application
- 6. Global Cannabinoid Biosynthesis Market Outlook: Region
- 6.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 6.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 6.2.1. North America
- 6.2.2. Latin America
- 6.2.3. Europe
- 6.2.4. East Asia
- 6.2.5. South Asia and Oceania
- 6.2.6. Middle East & Africa
- 6.3. Market Attractiveness Analysis: Region
- 7. North America Cannabinoid Biosynthesis Market Outlook
- 7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.1.1. By Country
- 7.1.2. By Product Type
- 7.1.3. By Source
- 7.1.4. By Application
- 7.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.2.1. U.S.
- 7.2.2. Canada
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 7.3.1. Phytocannabinoids
- 7.3.2. Synthetic Cannabinoids
- 7.3.3. Endocannabinoid System
- 7.3.4. Modulators
- 7.3.5. Cannabinoids
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 7.4.1. Cannabis Sativa
- 7.4.2. Cannabis Indica
- 7.4.3. Hemp-Derived Cannabinoids
- 7.4.4. Others
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Pharmaceuticals
- 7.5.2. Food and Beverages
- 7.5.3. Cosmetics and Personal Care
- 7.5.4. Healthcare Products
- 7.5.5. Aromatherapy and Wellness
- 7.5.6. Others
- 7.6. Market Attractiveness Analysis
- 8. Europe Cannabinoid Biosynthesis Market Outlook
- 8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.1.1. By Country
- 8.1.2. By Product Type
- 8.1.3. By Source
- 8.1.4. By Application
- 8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.2.1. Germany
- 8.2.2. France
- 8.2.3. U.K.
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Rest of Europe
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 8.3.1. Phytocannabinoids
- 8.3.2. Synthetic Cannabinoids
- 8.3.3. Endocannabinoid System
- 8.3.4. Modulators
- 8.3.5. Cannabinoids
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 8.4.1. Cannabis Sativa
- 8.4.2. Cannabis Indica
- 8.4.3. Hemp-Derived Cannabinoids
- 8.4.4. Others
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.5.1. Pharmaceuticals
- 8.5.2. Food and Beverages
- 8.5.3. Cosmetics and Personal Care
- 8.5.4. Healthcare Products
- 8.5.5. Aromatherapy and Wellness
- 8.5.6. Others
- 8.6. Market Attractiveness Analysis
- 9. East Asia Cannabinoid Biosynthesis Market Outlook
- 9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.1.1. By Country
- 9.1.2. By Product Type
- 9.1.3. By Source
- 9.1.4. By Application
- 9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.2.1. China
- 9.2.2. Japan
- 9.2.3. South Korea
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 9.3.1. Phytocannabinoids
- 9.3.2. Synthetic Cannabinoids
- 9.3.3. Endocannabinoid System, Modulators, Cannabinoids
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 9.4.1. Cannabis Sativa
- 9.4.2. Cannabis Indica
- 9.4.3. Hemp-Derived Cannabinoids
- 9.4.4. Others
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Pharmaceuticals
- 9.5.2. Food and Beverages
- 9.5.3. Cosmetics and Personal Care
- 9.5.4. Healthcare Products
- 9.5.5. Aromatherapy and Wellness
- 9.5.6. Others
- 9.6. Market Attractiveness Analysis
- 10. South Asia & Oceania Cannabinoid Biosynthesis Market Outlook
- 10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.1.1. By Country
- 10.1.2. By Product Type
- 10.1.3. By Source
- 10.1.4. By Application
- 10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.2.1. India
- 10.2.2. Indonesia
- 10.2.3. Thailand
- 10.2.4. Singapore
- 10.2.5. ANZ
- 10.2.6. Rest of South Asia & Oceania
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 10.3.1. Phytocannabinoids
- 10.3.2. Synthetic Cannabinoids
- 10.3.3. Endocannabinoid System
- 10.3.4. Modulators
- 10.3.5. Cannabinoids
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 10.4.1. Cannabis Sativa
- 10.4.2. Cannabis Indica
- 10.4.3. Hemp-Derived Cannabinoids
- 10.4.4. Others
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Pharmaceuticals
- 10.5.2. Food and Beverages
- 10.5.3. Cosmetics and Personal Care
- 10.5.4. Healthcare Products
- 10.5.5. Aromatherapy and Wellness
- 10.5.6. Others
- 10.6. Market Attractiveness Analysis
- 11. Latin America Cannabinoid Biosynthesis Market Outlook
- 11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.1.1. By Country
- 11.1.2. By Product Type
- 11.1.3. By Source
- 11.1.4. By Application
- 11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.2.1. Brazil
- 11.2.2. Mexico
- 11.2.3. Rest of Latin America
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 11.3.1. Phytocannabinoids
- 11.3.2. Synthetic Cannabinoids
- 11.3.3. Endocannabinoid System
- 11.3.4. Modulators
- 11.3.5. Cannabinoids
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 11.4.1. Cannabis Sativa
- 11.4.2. Cannabis Indica
- 11.4.3. Hemp-Derived Cannabinoids
- 11.4.4. Others
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Pharmaceuticals
- 11.5.2. Food and Beverages
- 11.5.3. Cosmetics and Personal Care
- 11.5.4. Healthcare Products
- 11.5.5. Aromatherapy and Wellness
- 11.5.6. Others
- 11.6. Market Attractiveness Analysis
- 12. Middle East & Africa Cannabinoid Biosynthesis Market Outlook
- 12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 12.1.1. By Country
- 12.1.2. By Product Type
- 12.1.3. By Source
- 12.1.4. By Application
- 12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.2.1. GCC Countries
- 12.2.2. Egypt
- 12.2.3. South Africa
- 12.2.4. Northern Africa
- 12.2.5. Rest of Middle East & Africa
- 12.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 12.3.1. Phytocannabinoids
- 12.3.2. Synthetic Cannabinoids
- 12.3.3. Endocannabinoid System
- 12.3.4. Modulators
- 12.3.5. Cannabinoids
- 12.4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
- 12.4.1. Cannabis Sativa
- 12.4.2. Cannabis Indica
- 12.4.3. Hemp-Derived Cannabinoids
- 12.4.4. Others
- 12.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 12.5.1. Pharmaceuticals
- 12.5.2. Food and Beverages
- 12.5.3. Cosmetics and Personal Care
- 12.5.4. Healthcare Products
- 12.5.5. Aromatherapy and Wellness
- 12.5.6. Others
- 12.6. Market Attractiveness Analysis
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2024
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Demetrix
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Product Type
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Ginko Bioworks
- 13.3.3. Hyasynth Biologicals
- 13.3.4. Creo
- 13.3.5. Amyris Inc
- 13.3.6. Zymergen Inc
- 13.3.7. Cronos Group Inc
- 13.3.8. Constellation Brands Inc
- 13.3.9. Jazz Pharmaceuticals PLC
- 13.3.10. Canopy Growth Corp
- 13.3.11. Evolva Holding SA
- 13.3.12. Willow Biosciences Inc
- 13.3.13. InMed Pharmaceuticals
- 13.3.14. CB Therapeutics
- 13.3.15. Lygos
- 13.3.16. Purisys
- 13.3.17. Renew Biopharma
- 13.3.18. Others
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
